Abstract:Natural killer (NK) cell can inhibit tumor initiation and regulates metastatic dissemination, acting as key mediators of the innate immune response. Intrinsic factors modulating NK cells infiltration and its anticancer activity remain poorly characterized. We investigated the roles of dysregulation of micro(mi) RNAs and NK cells in progression of hepatocellular carcinoma (HCC). Methods: Small RNA sequencing were used to detect the miRNA profiles of tumor tissues from HCC patients with (n=14) or without (n=13) pulmonary metastasis and HCC cell lines with different pulmonary metastatic potentials. Chemokine expression profiling and bioinformatics were used to detect the downstream target of candidate target. In gain-and loss-of-function assays were used to investigate the role of miRNA in HCC progression. Different subsets of NK cells were isolated and used for chemotaxis and functional assays in vivo and in vitro. In situ hybridization and immunohistochemical analyses were performed to detect the expression of miRNA in tumor tissues from 242 HCC patients undergoing curative resection from 2010. Results: Three miRNAs (miR-137, miR-149-5p, and miR-561-5p) were identified to be associated with pulmonary metastasis in patients with HCC. miR-561-5p was most highly overexpressed in metastatic HCC tissues and high-metastatic-potential HCC cell lines. In gain-and loss-of-function assays in a murine model, miR-561-5p promoted tumor growth and spread to the lungs. Yet, miR-561-5p did not appear to affect cellular proliferation and migration in vitro. Bioinformatics and chemokine expression profiling identified chemokine (C-X3-C motif) ligand 1 (CX(3)CL1) as a potential target of miR-561-5p. Furthermore, miR-561-5p promoted tumorigenesis and metastasis via CX(3)CL1-dependent regulation of CX(3)CR1(+) NK cell infiltration and function. CX(3)CR1(+) NK cells demonstrated stronger in vivo anti-metastatic activity relative to CX(3)CR1(-) NK cells. CX(3)CL1 stimulated chemotactic migration and cytotoxicity in CX(3)CR1(+) NK cells via STAT3 signaling. Blockade of CX(3)CL1, CX(3)CR1, or of pSTAT3 signaling pathways attenuated the antitumor responses. Clinical samples exhibited a negative correlation between miR-561-5p expression and levels of CX(3)CL1 and CX(3)CR1(+) NK cells. High miR-561-5p abundance, low CX(3)CL1 levels, and low numbers of CX(3)CR1(+) NK cells were associated with adverse prognosis. Conclusion: We delineated a miR-561-5p/CX(3)CL1/NK cell axis that drives HCC metastasis and demonstrated that CX(3)CR1(+) NK cells serve as potent antitumor therapeutic effectors.

NLRC3 silencing accelerates the invasion of hepatocellular carcinoma cell via IL‐6/JAK2/STAT3 pathway activation

Integrated Multiomics Reveals Silencing of Has_circ_0006646 Promotes TRIM21‐Mediated NCL Ubiquitination to Inhibit Hepatocellular Carcinoma Metastasis

NLRC3 High Expression Represents a Novel Predictor for Positive Overall Survival Correlated with CCL5 and CXCL9 in HCC Patients

NCR− Group 3 Innate Lymphoid Cells Orchestrate IL-23/IL-17 Axis to Promote Hepatocellular Carcinoma Development

The correlation of NLRC3 expression with the progression and prognosis of hepatocellular carcinoma

Suppression of Heterogeneous Nuclear Ribonucleoprotein C Inhibit Hepatocellular Carcinoma Proliferation, Migration, and Invasion via Ras/MAPK Signaling Pathway

Tim-3 Hampers Tumor Surveillance of Liver-Resident and Conventional NK Cells by Disrupting PI3K Signaling

LINC00707 promotes hepatocellular carcinoma progression through activating ERK/JNK/AKT pathway signaling pathway

Role of NLRP3 inflammasome activation in HCC cell progression

IL-6/STAT3 Is a Promising Therapeutic Target for Hepatocellular Carcinoma

Expression and clinical significance of NLRC5 in hepatocellular carcinoma

High Expression of LINC01268 is Positively Associated with Hepatocellular Carcinoma Progression via Regulating MAP3K7

NK Cells Are the Crucial Antitumor Mediators when STAT3-mediated Immunosuppression is Blocked in Hepatocellular Carcinoma.

LINC00680 enhances hepatocellular carcinoma stemness behavior and chemoresistance by sponging miR-568 to upregulate AKT3

Novel lncRNA AL033381.2 Promotes Hepatocellular Carcinoma Progression by Upregulating PRKRA Expression

LINC00624 affects hepatocellular carcinoma proliferation and apoptosis through the miR‐342‐3p/DNAJC5 axis

LncRNA HULC regulates hepatocellular carcinoma cell proliferation, apoptosis and epithelial-mesenchymal transition via the miR-372/CXCR4 axis

LINC00355 Triggers Malignant Progression of Hepatocellular Carcinoma Via the Sponge Effect on Mir-217-5p with the Involvement of the Wnt/β-catenin Signaling.

lncSNHG16 promotes hepatocellular carcinoma development by inhibiting autophagy

The miR-561-5p/CX 3 CL1 Signaling Axis Regulates Pulmonary Metastasis in Hepatocellular Carcinoma Involving CX 3 CR1 + Natural Killer Cells Infiltration.

Downregulation of SNAIL Sensitizes Hepatocellular Carcinoma Cells to TRAIL-induced Apoptosis by Regulating the NF-κB Pathway.